KELCIE THAMES: Open Payments
NPI 1457015703 · ROXBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$365 in 17 payments from 13 companies in 2025. Trend: 2023 $376 · 2024 $303 · 2025 $365
Food & beverage: $366
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 2 | $55 |
| Otsuka America Pharmaceutical, Inc. | 2 | $51 |
| Novartis Pharmaceuticals Corporation | 2 | $42 |
| Lilly USA, LLC | 2 | $37 |
| SANOFI-AVENTIS U.S. LLC | 1 | $28 |
| Phadia US Inc. | 1 | $23 |
| Boston Scientific Corporation | 1 | $23 |
| Abbott Laboratories | 1 | $21 |
| Novo Nordisk Inc | 1 | $20 |
| ABBVIE INC. | 1 | $20 |
Products named: Korlym, REXULTI, LEQVIO, MOUNJARO, TZIELD, ImmunoCAP, BodyGuardian, FREESTYLE LIBRE 3.
Industry payments across NC — which companies pay providers there.
